Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Prescient Therapeutics, Ltd.
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
Assistance Publique - Hôpitaux de Paris
Kyowa Kirin Co., Ltd.
SciTech Development, Inc.
City of Hope Medical Center
Barbara Ann Karmanos Cancer Institute
City of Hope Medical Center
Thomas Jefferson University
University College, London
4SC AG
Emory University
Kyowa Kirin Co., Ltd.
European Organisation for Research and Treatment of Cancer - EORTC
Stanford University
Stanford University
National Institutes of Health Clinical Center (CC)
University of Nebraska
Eastern Cooperative Oncology Group
Genmab
Stanford University
Genmab
Atara Biotherapeutics
Thomas Jefferson University
Elorac, Inc.
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
4SC AG
Northwestern University
European Organisation for Research and Treatment of Cancer - EORTC
Roswell Park Cancer Institute
AbbVie
Rochester General Hospital
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Barbara Ann Karmanos Cancer Institute
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
University of Texas Southwestern Medical Center
Canadian Cancer Trials Group
Barbara Ann Karmanos Cancer Institute
Mayo Clinic
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center